Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Oryzon Genomics designs new inhibitors of lysine-specific histone demethylase 1A

April 20, 2011

Galderma synthesizes novel ADAM 17 inhibitors

April 20, 2011

Merck KGaA designs new protein kinase inhibitors

April 20, 2011

Novel PI3K-alpha inhibitors patented by Roche for cancer

April 20, 2011

Amira Pharma patents new arachidonate 5-lipoxygenase inhibitors

April 19, 2011

New modulators presented of alpha-adrenoceptors, histamine, dopamine and serotonin receptors

April 19, 2011

Novel neuropeptide Y2 receptor agonists presented by Novartis

April 19, 2011

Galderma researchers present novel series of ADAM 17 inhibitors

April 19, 2011

Senju Pharma claims new polypeptides for corneal epithelial disorders

April 19, 2011

ChemoCentryx presents new CMKLR1 receptor ligands

April 18, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...